Taeho Greg Rhee, PhD, MSW

JCP
How to Value a Life Without Limits: Quantifying Suffering With Quality-Adjusted Life Years in Social Anxiety Disorder
Commentary

May 27, 2024

The authors discuss a recent intriguing study published in JCP by Patel et al.
,
JCP
Suicide Attempts and Health-Related Quality of Life
Original Research

February 27, 2023

People with recent suicide attempts have much lower mental health–related QOL than those with no attempt or an attempt in the distant past. Psychiatric and substance use comorbidities explain...
, ,
JCP
Effects of ECT in Comorbid Depression and Dementia
Original Research

January 25, 2023

Limited data suggest a role for electroconvulsive therapy (ECT) in treating behavioral and psychological symptoms of dementia. Using a larger sample size than in previous reports, this study examined...
, , , et al
JCP
Social Support and Suicidal Thoughts and Behaviors
Original Research

December 5, 2022

Greater diversity of social networks was more strongly associated with lower risks of suicidal thoughts and behaviors than perceived strength of social support.
, , , et al
JCP
Increased Admissions for Substance Use Disorder Among Older Adults, 2000–2017
Original Research

March 28, 2022

From 2000 to 2017, the number of older adults admitted for substance use disorder treatment increased by 203.7%, as compared to 13.0% in younger adults. This study looks at...
, ,
JCP
Original Research

July 28, 2020

The Affordable Care Act of 2010, implemented in 2014, expanded access to outpatient mental health services, potentially reducing reliance on emergency departments (EDs). This study examined trends in mental...
, ,
JCP
Original Research

July 7, 2020

How many older adults receive electroconvulsive therapy (ECT) for treatment-resistant depression? Among those who receive ECT, how many finish the course? What factors might predict patients' continuation of ECT?...
, , , et al
JCP
Original Research

February 13, 2018

Because recent research supports the effectiveness of antipsychotics in nonresponsive major depressive disorder, examining national prescribing trends for these drugs in MDD is a timely topic. Using data from...
, ,

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe